Cornerstone Planning Group
DNA icon

Cornerstone Planning Group’s Ginkgo Bioworks DNA Stock Holding History

Cornerstone Planning Group’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-1,500
Closed -$11.7K – 564
2026
Q2 		$11.7K Hold
1,500
– – ﹤0.01% 840
2026
Q1 		$14.6K Buy
+1,500
New +$12.5K ﹤0.01% 780

Other funds holding DNA

J.M. Forbes & Co
J.M. Forbes & Co Boston, Massachusetts $1.33B AUM 21.14% 1-Year Est. Return
Q Fund Management (Hong Kong)
Q Fund Management (Hong Kong) Hong Kong $104M AUM 789.73% 1-Year Est. Return
Boston Standard Wealth Management
Boston Standard Wealth Management Winchester, Massachusetts $696M AUM 8.98% 1-Year Est. Return
TriaGen Wealth Management
TriaGen Wealth Management Calabasas, California $413M AUM 35.91% 1-Year Est. Return
FNY Investment Advisers
FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Cornerstone Planning Group's DNA Position: Q3 2026 in Review

Cornerstone Planning Group sold out of Ginkgo Bioworks (DNA) in Q3 2026, closing a stake of 1,500 shares — an estimated $11.7K sold.

Cornerstone Planning Group first reported a position in DNA in Q1 2026 and held it in 2 quarters. The position peaked at $14.6K in Q1 2026. 22 funds tracked by Wall St. Rank hold DNA as of Q3 2026.

  • Cornerstone Planning Group reported no remaining Ginkgo Bioworks position as of Q3 2026 after selling out during the quarter.
  • Cornerstone Planning Group sold 1,500 Ginkgo Bioworks shares in Q3 2026, an estimated $11.7K.
  • Cornerstone Planning Group first reported a position in Ginkgo Bioworks in Q1 2026 and held it in 2 quarters.
  • Cornerstone Planning Group's Ginkgo Bioworks position peaked at $14.6K in Q1 2026.
  • 22 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.

Based on Cornerstone Planning Group's 13F filing for Q3 2026, filed 16 Oct 2026.